190 related articles for article (PubMed ID: 23625394)
1. Preparation of human cerebrospinal fluid for proteomics biomarker analysis.
Waybright TJ
Methods Mol Biol; 2013; 1002():61-70. PubMed ID: 23625394
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the human ventricular cerebrospinal fluid proteome obtained from hydrocephalic patients.
Waybright T; Avellino AM; Ellenbogen RG; Hollinger BJ; Veenstra TD; Morrison RS
J Proteomics; 2010 Apr; 73(6):1156-62. PubMed ID: 20176152
[TBL] [Abstract][Full Text] [Related]
3. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
[TBL] [Abstract][Full Text] [Related]
4. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
Maurer MH
Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting.
Fratantoni SA; Piersma SR; Jimenez CR
Proteomics Clin Appl; 2010 Jul; 4(6-7):613-7. PubMed ID: 21137079
[TBL] [Abstract][Full Text] [Related]
6. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
7. 2D DIGE of the cerebrospinal fluid proteome in neurological diseases.
Tumani H; Lehmensiek V; Lehnert S; Otto M; Brettschneider J
Expert Rev Proteomics; 2010 Feb; 7(1):29-38. PubMed ID: 20121474
[TBL] [Abstract][Full Text] [Related]
8. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
9. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
10. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
11. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
[TBL] [Abstract][Full Text] [Related]
12. Proteomics analysis of human cerebrospinal fluid.
Yuan X; Desiderio DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
[TBL] [Abstract][Full Text] [Related]
13. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid.
Yuan X; Desiderio DM
Proteomics; 2005 Feb; 5(2):541-50. PubMed ID: 15627968
[TBL] [Abstract][Full Text] [Related]
14. Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry.
Noben JP; Dumont D; Kwasnikowska N; Verhaert P; Somers V; Hupperts R; Stinissen P; Robben J
J Proteome Res; 2006 Jul; 5(7):1647-57. PubMed ID: 16823972
[TBL] [Abstract][Full Text] [Related]
15. Proteome studies of CSF in AD patients.
Davidsson P; Sjögren M
Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
[TBL] [Abstract][Full Text] [Related]
16. Quantitative profiling of polar cationic metabolites in human cerebrospinal fluid by reversed-phase nanoliquid chromatography/mass spectrometry.
Myint KT; Aoshima K; Tanaka S; Nakamura T; Oda Y
Anal Chem; 2009 Feb; 81(3):1121-9. PubMed ID: 19125563
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of the cerebrospinal fluid peptidome and proteome.
Zougman A; Pilch B; Podtelejnikov A; Kiehntopf M; Schnabel C; Kumar C; Mann M
J Proteome Res; 2008 Jan; 7(1):386-99. PubMed ID: 18052119
[TBL] [Abstract][Full Text] [Related]
19. A rapid method for preparation of the cerebrospinal fluid proteome.
Larssen E; Brede C; Hjelle AB; Øysaed KB; Tjensvoll AB; Omdal R; Ruoff P
Proteomics; 2015 Jan; 15(1):10-5. PubMed ID: 25307358
[TBL] [Abstract][Full Text] [Related]
20. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).
Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H
Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
